Subscribe

December 2022

Fenfluramine Approved for Seizures in Patients Aged ≥2 Years with Lennox-Gastaut Syndrome
Epilepsy
December 2022
The US Food and Drug Administration has approved fenfluramine for difficult-to-treat seizures in patients with Lennox-Gastaut syndrome.
Read More
Masitinib May Slow Disability Progression in Progressive MS
Multiple Sclerosis
December 2022
Clinical trial showed that masitinib reduced disability progression in patients with progressive multiple sclerosis.
Read More
Encouraging Response Trajectories for Eptinezumab for Chronic Migraine
Migraine
December 2022
A study of the response trajectory following treatment with eptinezumab showed that a strong early response can often be maintained, and a poor response can improve.
Read More

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.

Sign Up for Value-Based Care in Neurology

Subscribe to receive the free, monthly VBCN e‑newsletter.

© Amplity Health. All Rights Reserved. Privacy Policy.